Molecular and genetic targets within metastatic colorectal cancer and associated novel treatment advancements

Colorectal cancer results in the deaths of hundreds of thousands of patients worldwide each year, with incidence expected to rise over the next two decades. In the metastatic setting, cytotoxic therapy options remain limited, which is reflected in the meager improvement of patient survival rates. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cann, Christopher G., LaPelusa, Michael B., Cimino, Sarah K., Eng, Cathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319053/
https://www.ncbi.nlm.nih.gov/pubmed/37409250
http://dx.doi.org/10.3389/fonc.2023.1176950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319053/
https://www.ncbi.nlm.nih.gov/pubmed/37409250
http://dx.doi.org/10.3389/fonc.2023.1176950

Ejemplares similares